Isolation of human eosinophils: microbead method has no impact on IL-5 sustained viability

Abstract

Insights

Multi-antibody eosinophil isolation yields higher purity and comparable viability to anti-CD16 microbeads. This method offers a significant advantage for isolating large numbers of eosinophils, suggesting it should not be abandoned.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Previous research suggested abandoning multi-antibody eosinophil isolation due to low purity and accelerated apoptosis.
  • These findings contrasted with traditional anti-CD16 microbead isolation methods.

Purpose of the Study:

  • To investigate the universality of previous findings on multi-antibody eosinophil isolation.
  • To compare the purity and viability of eosinophils isolated using multi-antibody versus anti-CD16 microbead methods.

Main Methods:

  • Eosinophils were isolated from normal donor granulocyte packs using two distinct methods.
  • Purity and viability were assessed, including annexin-V/propidium-iodide staining.

Main Results:

  • Multi-antibody isolation resulted in substantially greater eosinophil purity (98%) compared to anti-CD16 microbeads (69%).
  • No significant difference in eosinophil survival was observed between the two isolation methods, even with interleukin-5 stimulation.

Conclusions:

  • Multi-antibody eosinophil isolation offers a significant advantage for isolating large quantities of eosinophils from concentrated leukocyte preparations.
  • The findings do not support completely abandoning multi-antibody eosinophil isolation, highlighting its utility.
  • Methodological considerations remain important in cell isolation techniques.

Related Concept Videos